Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 68071-2214 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 2214 9

pdp - 68071 2214 9

This appears to be a description of a medication, specifically Gabapentin 800mg tablets in a bottle of 90, with Lot # 000000 and NDC # 68071-2214-09. The tablets are white or off-white and scored on both sides. The bottle has an expiration date of 00-00 and is to be stored at a controlled temperature between 59-86°F. The manufacturer's NDC is 50228-178-05 and the tablet is serial number 00000000002 with a Product # P1293090. There is a warning to keep the medication out of reach of children and to contact 1-800-FDA-1083 in case of adverse reactions.*

Figure 1 - image 01

Figure 1 - image 01

This appears to be a chart or table displaying the mean pain score for two groups - one group receiving a fixed dose of medication called "Parkod" and another group receiving a high dose of Gabapentin. The table also displays the time period for the study, with baseline and several weeks indicated. Not enough information is provided to understand the context or purpose of the study.*

Figure 2 - image 02

Figure 2 - image 02

This appears to be a chart or graph showing the results of a study on the effects of Gabapentin on pain score over a 4-week fixed dose period. The study has a placebo group and two Gabapentin groups: one taking 1800 mg/day and the other taking 2400 mg/day. The pain score is measured on a scale of 0-10 and is shown to decrease over the duration of the study in both Gabapentin groups compared to the placebo group. However, without further context or information, it is difficult to fully understand the purpose and conclusions of the study.*

Figure 3 - image 03

Figure 3 - image 03

Cockcroft and Gault Equation - image 04

Cockcroft and Gault Equation - image 04

Gabapentin Structural Formula - image 05

Gabapentin Structural Formula - image 05

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.